Reuters logo
2 个月前
BRIEF-ARCA Biopharma announces database lock for genetic-af phase 2b interim efficacy analysis
2017年6月20日 / 下午1点15分 / 2 个月前

BRIEF-ARCA Biopharma announces database lock for genetic-af phase 2b interim efficacy analysis

June 20 (Reuters) - Arca Biopharma Inc

* ARCA Biopharma announces database lock for genetic-af phase 2b interim efficacy analysis – dsmb recommendation anticipated in august 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below